Counter Lab

Seth Zimmerman is a postdoctoral fellow at Duke University. He received his PhD from UNC Chapel Hill, studying cell migration and metastasis using optogenetic approaches. He now studies novel oncogenic pathways using screening technology to aid in identifying new therapeutic targets.